Records containing: Renal Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-272007 - Rene: Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Radical Nefrectomy/Tumorectomy Surgery
-
CLINICAL_TRIALS study record update · 2023-11-22KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer
-
CLINICAL_TRIALS study record update · 2023-08-02Robot-assisted Urological Surgeries Using the MicroHand S Robot: a Prospective, Single Blind, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-07-10A Multicenter, Open-label, Dose-escalating, Phase I Trial With GEM3PSCA, a PSCA Targeted Bispecific Antibody Engaging T-cells, in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSCA Marker
-
CLINICAL_TRIALS study record update · 2023-06-01Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer - a Randomised Trial of Functional, Oncological and Financial Aspects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-06-01Gag-layer in the Urothelium of the Human Upper Urinary Tract
-
CLINICAL_TRIALS study record update · 2023-04-25Which is Better to Assess Postoperative Complications in Patients Undergoing Laparoscopic Partial Nephrectomy?: Clavien-Dindo Classification Versus Comprehensive Complication Index.
-
CLINICAL_TRIALS study record update · 2023-04-19Predictive Role of Circulating Biomarkers Involved in Angiogenesis in Metastatic Kidney Cancer in the Era of New Therapeutic Associations: Immunotherapies, Anti-angiogenic
-
CLINICAL_TRIALS study record update · 2023-02-17Prospective Expression Analysis Using The Decipher Genomics Resource for Intelligent Discovery (GRID)® and Data Sharing Program
-
CLINICAL_TRIALS study record update · 2023-02-16An Observational Study to Evaluate the Microbiome as a Biomarker of Efficacy and Toxicity in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
-
CLINICAL_TRIALS study record update · 2022-12-02A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab (MEDI4736) Plus the Toll-like Receptor Agonist Poly-ICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
-
CLINICAL_TRIALS study record update · 2022-10-20Efficacy and Safety of Nivolumab in Metastatic Renal Cell Cancer Patients - Japanese Real-World Data Through Clinical Chart Review
-
CLINICAL_TRIALS study record update · 2022-08-11A First in Human, Phase 1 Safety Study in Two Parts to Determine the Safety, Tolerability and Anti-cancer Immune-modulatory Effects of MRx0518 in Patients With Solid Tumour Awaiting Surgical Removal of the Tumour.
-
CLINICAL_TRIALS study record update · 2022-06-22Study of the Relationship Between the Blood Levels of Soluble PDL1 and β2-microglobulin, and the Clinical Course of a Metastatic Solid Tumor Treated With a First-line Therapeutic of Checkpoint Immune Inhibitor
-
CLINICAL_TRIALS study record update · 2022-06-09Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors
-
CLINICAL_TRIALS study record update · 2022-04-25Phase II Study of Optimized Management of NIVOlumab Based on REsponse in Patients With Advanced Renal Cell Carcinoma (OMNIVORE Study)
-
CLINICAL_TRIALS study record update · 2022-04-11Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS): an International Multicenter Study
-
CLINICAL_TRIALS study record update · 2022-03-29A Phase I/II Study of the Treatment of Metastatic Cancer That Expresses MAGE-A3 Using Lymphodepleting Conditioning Followed by Infusion of HLA-DP0401/0402 Restricted Anti-MAGE-A3 TCR-Gene Engineered Lymphocytes and Aldesleukin
-
CLINICAL_TRIALS study record update · 2022-01-31A Phase I/Ib, Open-label, Multi-center Dose Escalation Study of NIS793 in Combination With PDR001 in Adult Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2022-01-14Treatment of Metastatic Tumors of the Urogenital Area (Bladder Cancer, Renal Cancel) With Cytokine-induced Killer Cells
-
CLINICAL_TRIALS study record update · 2022-01-13Complications Associated With Partial Nephrectomy for Renal Cancer: PMSI French National Data
-
CLINICAL_TRIALS study record update · 2021-07-16Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
-
CLINICAL_TRIALS study record update · 2021-06-22Comparison of Laparoscopic Partial Nephrectomy Versus Laparoscopic Radical Nephrectomy in Patients With High-Complexity Renal Tumors: A Propensity Score Matched Analysis
-
CLINICAL_TRIALS study record update · 2021-05-14Pilot Study of Iodine-124 Labeled Chimeric G250 (124I-cG250) in Presurgical Patients With Renal Masses
-
CLINICAL_TRIALS study record update · 2021-02-24A Phase II Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma